These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 2911028)

  • 1. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.
    Riederer P; Sofic E; Rausch WD; Schmidt B; Reynolds GP; Jellinger K; Youdim MB
    J Neurochem; 1989 Feb; 52(2):515-20. PubMed ID: 2911028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
    Dexter DT; Wells FR; Lees AJ; Agid F; Agid Y; Jenner P; Marsden CD
    J Neurochem; 1989 Jun; 52(6):1830-6. PubMed ID: 2723638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.
    Sofic E; Riederer P; Heinsen H; Beckmann H; Reynolds GP; Hebenstreit G; Youdim MB
    J Neural Transm; 1988; 74(3):199-205. PubMed ID: 3210014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group.
    Dexter DT; Jenner P; Schapira AH; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S94-100. PubMed ID: 1510387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats.
    Tarohda T; Ishida Y; Kawai K; Yamamoto M; Amano R
    Anal Bioanal Chem; 2005 Sep; 383(2):224-34. PubMed ID: 16132122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased ferritin levels in brain in Parkinson's disease.
    Dexter DT; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees AJ; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1990 Jul; 55(1):16-20. PubMed ID: 2355217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.
    Sofic E; Paulus W; Jellinger K; Riederer P; Youdim MB
    J Neurochem; 1991 Mar; 56(3):978-82. PubMed ID: 1704426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
    Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
    Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra.
    Galazka-Friedman J; Bauminger ER; Koziorowski D; Friedman A
    Biochim Biophys Acta; 2004 Mar; 1688(2):130-6. PubMed ID: 14990343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
    Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
    Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.
    Zecca L; Stroppolo A; Gatti A; Tampellini D; Toscani M; Gallorini M; Giaveri G; Arosio P; Santambrogio P; Fariello RG; Karatekin E; Kleinman MH; Turro N; Hornykiewicz O; Zucca FA
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9843-8. PubMed ID: 15210960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study.
    He Y; Thong PS; Lee T; Leong SK; Shi CY; Wong PT; Yuan SY; Watt F
    Brain Res; 1996 Sep; 735(1):149-53. PubMed ID: 8905180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.
    Faucheux BA; Martin ME; Beaumont C; Hunot S; Hauw JJ; Agid Y; Hirsch EC
    J Neurochem; 2002 Oct; 83(2):320-30. PubMed ID: 12423242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease.
    Yeager MP; Coleman RA
    J Neurosci Methods; 2010 Apr; 188(1):151-64. PubMed ID: 20144654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
    Hirsch EC; Brandel JP; Galle P; Javoy-Agid F; Agid Y
    J Neurochem; 1991 Feb; 56(2):446-51. PubMed ID: 1988548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
    Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium, magnesium and aluminum concentrations in Parkinson's disease.
    Yasui M; Kihira T; Ota K
    Neurotoxicology; 1992; 13(3):593-600. PubMed ID: 1475063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains.
    Connor JR; Snyder BS; Arosio P; Loeffler DA; LeWitt P
    J Neurochem; 1995 Aug; 65(2):717-24. PubMed ID: 7616228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.
    Genoud S; Roberts BR; Gunn AP; Halliday GM; Lewis SJG; Ball HJ; Hare DJ; Double KL
    Metallomics; 2017 Oct; 9(10):1447-1455. PubMed ID: 28944802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.